nach oben

Intensive Care Medicine

Erschienen in:

23.01.2020 | Understanding the Disease

Why we need safer anticoagulant strategies for patients on short-term percutaneous mechanical circulatory support

verfasst von: Christophe Vandenbriele, Thomas Vanassche, Susanna Price

Erschienen in: Intensive Care Medicine | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Excerpt

The field of percutaneous mechanical circulatory support (pMCS) and by extension of critical care has evolved markedly over recent years. In particular, the use of extracorporeal membrane oxygenation (ECMO) of balloon pumps and more recently microaxial-flow pumps has become more reliable with steadily improving technology and increasing experience, reflected in its improving results. Also, the possible duration of MCS support has greatly increased (from days to weeks) due to improved oxygenators and better medical management in dedicated high-volume ECMO centres [1]. …

Abrams D, Garan AR, Abdelbary A, Bacchetta M, Bartlett RH, Beck J, Belohlavek J, Chen YS, Fan E, Ferguson ND, Fowles JA, Fraser J, Gong M, Hassan IF, Hodgson C, Hou X, Hryniewicz K, Ichiba S, Jakobleff WA, Lorusso R, MacLaren G, McGuinness S, Mueller T, Park PK, Peek G, Pellegrino V, Price S, Rosenzweig EB, Sakamoto T, Salazar L, Schmidt M, Slutsky AS, Spaulding C, Takayama H, Takeda K, Vuylsteke A, Combes A, Brodie D, International EN, The Extracorporeal Life Support O (2018) Position paper for the organization of ECMO programs for cardiac failure in adults. Intensive Care Med 44:717–729CrossRef

Husain-Syed F, Ricci Z, Brodie D, Vincent JL, Ranieri VM, Slutsky AS, Taccone FS, Gattinoni L, Ronco C (2018) Extracorporeal organ support (ECOS) in critical illness and acute kidney injury: from native to artificial organ crosstalk. Intensive Care Med 44:1447–1459CrossRef

Fisser C, Reichenbacher C, Muller T, Schneckenpointner R, Malfertheiner MV, Philipp A, Foltan M, Lunz D, Zeman F, Lubnow M (2019) Incidence and risk factors for cannula-related venous thrombosis after venovenous extracorporeal membrane oxygenation in adult patients with acute respiratory failure. Crit Care Med 47:e332–e339CrossRef

Annich GM (2015) Extracorporeal life support: the precarious balance of hemostasis. J Thromb Haemost 13(Suppl 1):S336–342CrossRef

Luyt CE, Brechot N, Demondion P, Jovanovic T, Hekimian G, Lebreton G, Nieszkowska A, Schmidt M, Trouillet JL, Leprince P, Chastre J, Combes A (2016) Brain injury during venovenous extracorporeal membrane oxygenation. Intensive Care Med 42:897–907CrossRef

Cheng R, Hachamovitch R, Kittleson M, Patel J, Arabia F, Moriguchi J, Esmailian F, Azarbal B (2014) Complications of extracorporeal membrane oxygenation for treatment of cardiogenic shock and cardiac arrest: a meta-analysis of 1866 adult patients. Ann Thorac Surg 97:610–616CrossRef

Protti A, Iapichino GE, Di Nardo M, Panigada M, Gattinoni L, (2019) Anticoagulation management and antithrombin supplementation practice during veno-venous extracorporeal membrane oxygenation: a worldwide survey. Anesthesiology.

Wong TE, Nguyen T, Shah SS, Brogan TV, Witmer CM (2016) Antithrombin concentrate use in pediatric extracorporeal membrane oxygenation: a multicenter cohort study. Pediatr Crit Care Med 17:1170–1178CrossRef

Arnouk S, Altshuler D, Lewis TC, Merchan C, Smith DE, 3rd, Toy B, Zakhary B, Papadopoulos J (2019) Evaluation of anti-xa and activated partial thromboplastin time monitoring of heparin in adult patients receiving extracorporeal membrane oxygenation support. ASAIO J. https://doi.org/10.1097/MAT.0000000000001004

10.

Panigada M, Iapichino GE, Brioni M, Panarello G, Protti A, Grasselli G, Occhipinti G, Novembrino C, Consonni D, Arcadipane A, Gattinoni L, Pesenti A (2018) Thromboelastography-based anticoagulation management during extracorporeal membrane oxygenation: a safety and feasibility pilot study. Ann Intensive Care 8:7CrossRef

11.

Kimmoun A, Oulehri W, Sonneville R, Grisot PH, Zogheib E, Amour J, Aissaoui N, Megarbane B, Mongardon N, Renou A, Schmidt M, Besnier E, Delmas C, Dessertaine G, Guidon C, Nesseler N, Labro G, Rozec B, Pierrot M, Helms J, Bougon D, Chardonnal L, Medard A, Ouattara A, Girerd N, Lamiral Z, Borie M, Ajzenberg N, Levy B (2018) Prevalence and outcome of heparin-induced thrombocytopenia diagnosed under veno-arterial extracorporeal membrane oxygenation: a retrospective nationwide study. Intensive Care Med 44:1460–1469CrossRef

12.

Selleng S, Selleng K (2016) Heparin-induced thrombocytopenia in cardiac surgery and critically ill patients. Thromb Haemost 116:843–851CrossRef

13.

Bein T, Zimmermann M, Philipp A, Ramming M, Sinner B, Schmid C, Muller T, Graf B, Schlitt HJ, Weber-Carstens S (2011) Addition of acetylsalicylic acid to heparin for anticoagulation management during pumpless extracorporeal lung assist. ASAIO J 57:164–168CrossRef

14.

Schellongowski P, Combes A, Moller MH (2018) Focus on extracorporeal life support. Intensive Care Med 44:2251–2253CrossRef

15.

Beitelshees AL, Voora D, Lewis JP (2015) Personalized antiplatelet and anticoagulation therapy: applications and significance of pharmacogenomics. Pharmgenomics Pers Med 8:43–61PubMedPubMedCentral

16.

Weitz JI (2016) Factor XI and factor XII as targets for new anticoagulants. Thromb Res 141(Suppl 2):S40–45CrossRef

17.

Krueger K, Schmutz A, Zieger B, Kalbhenn J (2017) Venovenous extracorporeal membrane oxygenation with prophylactic subcutaneous anticoagulation only: an observational study in more than 60 patients. Artif Organs 41:186–192CrossRef

18.

Sanfilippo F, Asmussen S, Maybauer DM, Santonocito C, Fraser JF, Erdoes G, Maybauer MO (2017) Bivalirudin for alternative anticoagulation in extracorporeal membrane oxygenation: a systematic review. J Intensive Care Med 32:312–319CrossRef

19.

Rouge A, Pelen F, Durand M, Schwebel C (2017) Argatroban for an alternative anticoagulant in HIT during ECMO. J Intensive Care 5:39CrossRef

20.

Ontaneda A, Annich GM (2018) Novel surfaces in extracorporeal membrane oxygenation circuits. Front Med (Lausanne) 5:321CrossRef

21.

Staudacher DL, Biever PM, Benk C, Ahrens I, Bode C, Wengenmayer T (2016) Dual Antiplatelet Therapy (DAPT) versus no antiplatelet therapy and incidence of major bleeding in patients on venoarterial extracorporeal membrane oxygenation. PLoS ONE 11:e0159973CrossRef

Titel: Why we need safer anticoagulant strategies for patients on short-term percutaneous mechanical circulatory support
verfasst von: Christophe Vandenbriele
Thomas Vanassche
Susanna Price
Publikationsdatum: 23.01.2020
Verlag: Springer Berlin Heidelberg
Erschienen in: Intensive Care Medicine / Ausgabe 4/2020
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-019-05897-3

Neu im Fachgebiet AINS

23.04.2024 | Appendizitis | Nachrichten

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren

Springer Medizin

Why we need safer anticoagulant strategies for patients on short-term percutaneous mechanical circulatory support

Excerpt

Neu im Fachgebiet AINS

Hinter dieser Appendizitis steckte ein Erreger

Ärztliche Empathie hilft gegen Rückenschmerzen

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

S3-Leitlinie zu Pankreaskrebs aktualisiert

Update AINS

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2020

Prolonged elevation of plasma HMGB1 is associated with cognitive impairment in intensive care unit survivors

Focus on infection

Prehospital identification of community sepsis using biomarkers of host response

Methylnaltrexone for the treatment of opioid-induced constipation and gastrointestinal stasis in intensive care patients. Results from the MOTION trial

Respiratory drive in the acute respiratory distress syndrome: pathophysiology, monitoring, and therapeutic interventions

Focus on clinical trial interpretation

Neu im Fachgebiet AINS

Hinter dieser Appendizitis steckte ein Erreger

Ärztliche Empathie hilft gegen Rückenschmerzen

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

S3-Leitlinie zu Pankreaskrebs aktualisiert

Update AINS